Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Short-term Investments: 2009-2022

Historic Short-term Investments for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Sep 2022 value amounting to $45.8 million.

  • Avadel Pharmaceuticals' Short-term Investments fell 62.77% to $45.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $45.8 million, marking a year-over-year decrease of 62.77%. This contributed to the annual value of $106.5 million for FY2021, which is 28.84% down from last year.
  • Avadel Pharmaceuticals' Short-term Investments amounted to $45.8 million in Q3 2022, which was down 8.47% from $50.0 million recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Short-term Investments registered a high of $157.3 million during Q1 2018, and its lowest value of $40.0 million during Q1 2020.
  • Its 3-year average for Short-term Investments is $104.0 million, with a median of $122.9 million in 2021.
  • In the last 5 years, Avadel Pharmaceuticals' Short-term Investments spiked by 264.72% in 2021 and then slumped by 63.16% in 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Short-term Investments (Quarterly) stood at $90.6 million in 2018, then slumped by 39.97% to $54.4 million in 2019, then surged by 175.23% to $149.7 million in 2020, then dropped by 28.84% to $106.5 million in 2021, then crashed by 62.77% to $45.8 million in 2022.
  • Its Short-term Investments stands at $45.8 million for Q3 2022, versus $50.0 million for Q2 2022 and $62.6 million for Q1 2022.